Skip to content
Trial Eligibility
Menu

Crohn's Disease Clinical Trials near Orlando, FL

Illustration: An adult preparing a simple bowl of soup in a warm, uncluttered kitchen
Illustration of Orlando, FL

21 studies for Crohn's Disease are recruiting at 38 sites within 50 miles of Orlando, Florida, according to ClinicalTrials.gov data processed .

Distances are city-level approximations. See all Crohn's Disease trials in the US or all trials near Orlando.

Your ZIP is looked up in your browser. We don't receive or store it.

Recruiting now

Crohn's Disease studies enrolling near Orlando

Showing 21 studies, nearest first.
  1. An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

    NCT07184931

    • Phase 3
    • Ages 16 to 80 years
    • Sex: All

    Nearest sites: AdventHealth Orlando-Site Number: 8400070 (Orlando, FL); Orlando Health, Inc.-Site Number: 8400084 (Orlando, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    4 sites within 50 mi
  2. Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease

    NCT06548542

    • Phase 2
    • Ages 18 to 75 years
    • Sex: All

    Nearest sites: Endoscopic Research, Inc. /ID# 267211 (Orlando, FL); Novum Research /ID# 278128 (Clermont, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  3. A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting

    NCT06581328

    • Phase 4
    • Ages 18 to 80 years
    • Sex: All

    Nearest sites: Endoscopic Research, Inc. (Orlando, FL); Orlando Health-Orlando Regional Medical Center (Orlando, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  4. A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease

    NCT06819891

    • Phase 3
    • Ages 16 to 80 years
    • Sex: All

    Nearest sites: Digestive and Liver Center of Florida (Orlando, FL); Advanced Medical Research Center (Port Orange, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  5. A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease

    NCT06226883

    • Phase 2
    • Ages 18 to 85 years
    • Sex: All

    Nearest sites: Endoscopic Research Inc (Orlando, FL); Clinical Research of Osceola (Kissimmee, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  6. A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

    NCT06430801

    • Phase 3
    • Ages 16 to 80 years
    • Sex: All

    Nearest sites: AdventHealth Orlando ( Site 5131) (Orlando, FL); Endoscopic Research Inc ( Site 5061) (Orlando, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  7. Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease

    NCT06456593

    • Phase 2
    • Ages 18 to 75 years
    • Sex: All

    Nearest sites: Orlando Health, Inc. (Orlando, FL); Auzmer Research (Lakeland, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  8. A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease

    NCT06819878

    • Phase 3
    • Ages 16 to 80 years
    • Sex: All

    Nearest sites: Orlando Regional Healthcare (Orlando, FL); Clinical Research of Osceola, LLC (Kissimmee, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  9. Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

    NCT06937099

    • Phase 3
    • Ages 18 to 70 years
    • Sex: All

    Nearest sites: Digestive and Liver Center of Florida (Orlando, FL); Orlando Health (Orlando, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  10. A Study to Investigate Efficacy and Safety of Brivekimig in Participants With Crohn's Disease

    NCT06958536

    • Phase 2
    • Ages 18 to 75 years
    • Sex: All

    Nearest sites: Investigational Site Number: 8400007 (Orlando, FL); Investigational Site Number: 8400017 (Kissimmee, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  11. A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

    NCT07184944

    • Phase 3
    • Ages 16 to 80 years
    • Sex: All

    Nearest sites: Orlando Health, Inc., Digestive Health Institute-Site Number: 8400084 (Orlando, FL); Clinical Research of Osceola-Site Number: 8400013 (Kissimmee, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  12. Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

    NCT07697456

    • Phase 2
    • Ages 18 to 75 years
    • Sex: All

    Nearest sites: Digestive And Liver Center Of Florida - Orlando /ID# 280924 (Orlando, FL); Clinical Research of Osceola /ID# 280593 (Kissimmee, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  13. Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission

    NCT05230173

    • Interventional
    • Ages 18 years and older
    • Sex: All

    Nearest site: Advent Health (Orlando, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  14. A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease

    NCT05995353

    • Phase 3
    • Ages 2 to 17 years
    • Sex: All

    Nearest site: Arnold Palmer Hospital for Children Center Digestive Health and Nutrition-Orland /ID# 255437 (Orlando, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  15. Open-label Single-arm Study to Assess the Efficacy of Mirikizumab in Patients With Inflammatory Strictures Due to CD

    NCT06997965

    • Phase 4
    • Ages 18 years and older
    • Sex: All

    Nearest site: Digestive & Liver Center of Florida (Orlando, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  16. A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease

    NCT07113522

    • Phase 2
    • Ages 18 to 80 years
    • Sex: All

    Nearest site: Mirador Therapeutics Selected Site (Orlando, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  17. Zymfentra (Infliximab-dyyb) REal World Cohort STudy

    NCT07237516

    • Observational
    • Ages 18 years and older
    • Sex: All

    Nearest site: AdventHealth (Orlando, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  18. A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease

    NCT07499232

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest site: Orlando Health Digestive Health Institute (Orlando, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  19. A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease

    NCT07577843

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest site: Endoscopic Research Inc (Orlando, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  20. A Study of SL-325 in Crohn's Disease Patients

    NCT07753850

    • Phase 2
    • Ages 18 to 80 years
    • Sex: All

    Nearest site: Clinical Trial Site (Kissimmee, FL)

    Distance to nearest recruiting site
    ~16 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  21. A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease

    NCT06233461

    • Phase 2
    • Ages 18 to 75 years
    • Sex: All

    Nearest site: Auzmer Research (Lakeland, FL)

    Distance to nearest recruiting site
    ~49 mi (city-level)
    Recruiting sites
    1 site within 50 mi

FAQ

Common questions

What is a clinical trial?
A clinical trial is a research study in people that tests a medical, surgical or behavioral intervention, such as an investigational drug or device. Observational studies are also listed: they collect information without assigning a treatment. Read how clinical trials work.
Is there compensation for joining a Crohn's Disease clinical trial?
Compensation for time and travel may be available, but it varies by study and some studies offer none. The amount and schedule are reviewed by an ethics board and described in the consent form. See compensation in clinical trials.
How do I check if I'm eligible?
Each study lists age, sex and other inclusion and exclusion criteria on its ClinicalTrials.gov record. Only the study team can confirm eligibility, usually through a screening call or visit. Talk with your own doctor before joining any study.

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.